Related Experiment Videos
Myeloperoxidase binds to vascular endothelial cells, is recognized by ANCA and can enhance complement dependent
C O Savage1, G Gaskin, C D Pusey
1Vascular Biology Section, Clinical Research Centre, Harrow, U.K.
Abstract:
Myeloperoxidase (MPO) and proteinase-3 (Pr-3) can bind to vascular endothelial cells (EC) and are available for recognition by autoantibodies present in P-ANCA or C-ANCA containing sera, respectively. The bound MPO also retains its enzymic functions and effectively interacts with hydrogen peroxide to mediate detachment of endothelial cells from their substratum. EC bound MPO-anti-MPO complexes can contribute to the complement-dependent EC injury demonstrated by some P-ANCA sera.
Insights
Myeloperoxidase (MPO) binds to endothelial cells, retaining its function to cause cell detachment. Anti-MPO antibodies in P-ANCA sera contribute to this injury via complement activation.
Area of Science:
- Immunology
- Vascular Biology
- Cellular Biochemistry
Background:
- Myeloperoxidase (MPO) and Proteinase-3 (Pr-3) are key autoantigens in ANCA-associated vasculitis.
- These proteins can interact with vascular endothelial cells (EC).
Purpose of the Study:
- To investigate the interaction of MPO with EC.
- To determine the functional consequences of MPO binding to EC.
- To elucidate the role of MPO-autoantibody complexes in EC injury.
Main Methods:
- Binding assays of MPO to EC.
- Enzymatic activity assays of bound MPO.
- Assessment of EC detachment.
- Complement-dependent cytotoxicity assays.
Main Results:
- MPO binds to EC and retains enzymatic activity.
- Bound MPO mediates EC detachment from the substratum.
- MPO-anti-MPO complexes contribute to complement-dependent EC injury in P-ANCA sera.
Conclusions:
- MPO binding to EC is a critical step in P-ANCA-mediated pathogenesis.
- Enzymatically active MPO on EC surfaces contributes to vascular damage.
- Autoantibodies targeting MPO can induce EC injury through complement activation.